Nuclear receptor and target gene mRNA abundance in duodenum and colon of dogs with chronic enteropathies

Domestic Animal Endocrinology

Volumn 31, Issue 4, 2006, Pages 327-339

  Greger, D L ^a   Gropp, F ^a   Morel, C ^a   Sauter, S ^a   Blum, J W ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Chronic diarrhea; Dog; Intestine; Nuclear receptor target genes; Nuclear receptors

Indexed keywords

CELL RECEPTOR; MESSENGER RNA;

ANIMAL; ANIMAL DISEASE; ARTICLE; COLON; DIARRHEA; DOG; DOG DISEASE; DUODENUM; ENTERITIS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; INTESTINE; MALE; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; COLON; DIARRHEA; DOG DISEASES; DOGS; DUODENUM; FEMALE; GENE EXPRESSION REGULATION; INFLAMMATORY BOWEL DISEASES; INTESTINES; MALE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

CANIS FAMILIARIS;

EID: 33749530205     PISSN: 07397240     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.domaniend.2005.12.002     Document Type: Article

References (41)

1. Allenspach K., and Gaschen F. Chronische Darmerkrankungen beim Hund: Eine Uebersicht. Schweiz Arch Tierheilk 145 (2003) 209-222
2. Paterson S. Food hypersensitivity in 20 dogs with skin and gastrointestinal signs. J Small Anim Pract 36 (1995) 529-534
3. Mizoguchi A., Mizoguchi E., and Bhan A.K. Immune networks in animal models of inflammatory bowel disease. Inflammatory Bowel Disease 9 (2003) 246-259
4. Jergens A.E. Inflammatory bowel disease. Current perspectives. Vet Clin North Am Small Anim Pract 29 (1999) 501-521
5. Leib M.S. Inflammatory bowel disease in dogs and cats. Proc World Small Anim Veterinary Assoc Congress (1994) 355-357
6. German A.J., Hall E.J., and Day M.J. Chronic intestinal inflammation and intestinal disease in dogs. J Vet Intern Med 17 (2003) 8-20
7. Dubuquoy L., Jansson E.A., Deeb S., Rakotobe S., Karoui M., Colombel J.F., et al. Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology 124 (2003) 1265-1276
8. Panwala C.M., Jones J.C., and Viney J.L. A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, MDR1A, spontaneously develop colitis. J Immunol 161 (1998) 5733-5744
9. Langmann T., Moehle C., Mauerer R., Scharl M., Liebisch G., Zahn A., et al. Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes. Gastroenterology 127 (2004) 26-40
10. Rousseaux C., Lefebvre B., Dubuquoy L., Lefebvre P., Romano O., Auwerx J., et al. Intestinal anti-inflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-γ. J Exp Med 201 (2005) 1205-1215
11. Clapper M.L., Adrian R.H., Pfeiffer G.R., Kido K., Everley L., Cooper H.S., et al. Depletion of colonic detoxication enzyme activity in mice with dextran sulphate sodium-induced colitis. Aliment Pharmacol Ther 13 (1999) 389-396
12. Bassaganya-Riera J., Reynolds K., Martino-Catt S., Cui Y., Henninghausen L., Gonzalez F., et al. Activation of PPARγ and δ by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease. Gastroenterology 127 (2004) 777-791
13. Desreumaux P., Dubuquoy L., Nutten S., Peuchmaur M., Englaro W., Schoonjans K., et al. Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor γ (PPAR γ) heterodimer: a basis for new therapeutic strategies. J Exp Med 7 (2001) 827-838
14. Germain P., Altucci L., Bourguet W., Rochette-Egly C., and Gronemeyer H. Nuclear receptor superfamily: principles of signalling. Pure Appl Chem 75 (2003) 1619-1664
15. Jergens A.E., Schreiner C.A., Frank D.E., Niyo Y., Ahrens F.E., Eckersall P.D., et al. A scoring index for disease activity in canine inflammatory bowel disease. J Vet Intern Med 17 (2003) 291-297
16. Spichiger A.C., Allenspach K., Ontsouka E., Gaschen F., Morel C., Blum J.W., et al. Abundance of mRNA of growth hormone receptor and insulin-like growth factors-1 and -2 in duodenal and colonic biopsies of dogs with chronic enteropathies. J Vet Med A 52 (2005) 491-497
17. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3 (2002) [research0034.1-0034.11]
18. SAS Institute. SAS Users guide (1994), SAS Institute, Statistics Cary, NC
19. Sauter S.N., Allenspach K., Gaschen F., Ontsouka E., Benyacoub J., Knorr R., et al. Effects of probiotic bacteria on intestinal mRNA cytokine expression patterns in dogs with food-responsive diarrhea. Proc Soc Nutr Physiol (2005) [abstract]
20. Chinetti G., Fruchart J.C., and Staels B. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res 49 (2000) 497-505
21. Harris S.G., and Phipps R.P. The nuclear receptor PPAR gamma is expressed by mouse T lymphocytes and PPAR gamma agonists induce apoptosis. Eur J Immunol 31 (2001) 1098-1105
22. Devchand P.R., Keller H., Peters J.M., Vasquez M., Gonzalez F.J., and Wahli W. The PPARα-leukotriene B4 pathway to inflammation control. Nature 384 (1996) 39-43
23. Dubuquoy L., Dharancy S., Nutten S., Pettersson S., Auwerx J., and Desreumaux P. Role of peroxisome proliferator-activated receptor γ and retinoid x receptor heterodimer in hepatogastroenterological disease. Lancet 360 (2002) 1410-1418
24. Kanno Y., Moriyama T., Ichikawa H., Mizuno M., Nakahama T., and Inouye Y. Transcriptional determination of sexually dimorphic expression of nuclear receptor constitutively active receptor (CAR) in Wistar rats. J Health Sci 50 (2004) 384-388
25. Pascussi J.M., Gerbal C.S., Pichard G.L., Daujat M., Fabre J.M., Maurel P., et al. Interleukin-6 negatively regulates the expression of pregnane X receptor and constutively activated receptor in primary human hepatcytes. Biochem Biophys Res Commun 274 (2000) 707-713
26. Geick A., Eichelbaum M., and Burk O. Nuclear receptor response elements mediate induction of intestinal MDR1 by Rifampin. J Biol Chem 276 (2001) 14581-14587
27. Burk O., Arnold K.A., Geick A., Tegude H., and Eichelbaum M. A role for constitutive androstane receptor in the regulation of human intestinal MDR1 expression. Biol Chem 386 (2005) 503-513
28. Stein U., Walter W., and Shoemaker R.H. Modulation of MDR1 expression by cytokines in human colon carcinoma cells: an approach for reversal of multidrug resistance. Br J Cancer 74 (1996) 1384-1391
29. Allenspach K, Bergman PJ, Sauter S, Gröne A, Doherr MG, Gaschen F. P-glycoprotein expression in lamina propria lymphocytes of duodenal biopsies in dogs with chronic idiopathic enteropathies. J Comp Pathol, in press.
30. Farrell R.J., Murphy A., Long A., Donelly S., Cherikuri A., O'Toole D., et al. High multidrug resistance (P-Glycoprotein 170) expression in inflammatory bowel disease patients who failed medical therapy. Gastroenterology 118 (2000) 278-288
31. Hsing S., Gatmaitan Z., and Arias I.M. The function of Gp170, the multidrug-resistance gene product, in the brush border of rat intestinal mucosa. Gastroenterology 102 (1992) 879-885
32. Richter K.P. Lymphocytic-plasmacytic enterocolitis in dogs. Semin Vet Med Surg (Small Anim) 7 (1992) 134-144
33. Endicott J.A., and Ling V. The biochemistry of P-glycoprotein mediated multidrug resistance. Annu Rev Biochem 58 (1989) 137-171
34. Thörn M., Finnström N., Lundgren S., Rane A., and Lööf L. Cytochromes P450 and MDR1 mRNA expression along the human gastrointestinal tract. Br J Clin Pharmacol 60 (2005) 54-60
35. Cherrington N.J., Hartley D.P., Li N., Johnson D.R., and Klaassen C.D. Organ distribution of multidrug resistance proteins 1,2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of MRP3 by constitutive androstane receptor activators in rats. J Pharmacol Exp Ther 300 (2002) 97-104
36. Kast H.R., Goodwin B., Tarr P.T., Jones S.A., Anisfeld A.M., Stoltz C.M., et al. Regulation of multidrug resistance-associated protein2 (ABCC2) by the nuclear receptors pregnane X receptor, Farnesoid X-activated receptor, and constitutive androstone receptor. J Biol Chem 277 (2002) 2908-2915
37. Nebert D.W., and Gonzalez F.J. P450 genes: structure, evolution, and regulation. Ann Rev Biochem 56 (1987) 945-993
38. Maurel P. The CYP3A family. In: Ioannides C. (Ed). Cytochromes P450: metabolic and toxiological aspects (1996), CRC Press, Inc., Boca Raton, FL 241-270
39. Lehmann J.M., McKee D.D., Watson M.A., Willson T.M., Moore J.T., and Kliewer S.A. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 102 (1998) 1016-1023
40. Klaassen C.D., Liu L., and Dunn R.T. Regulation of sulfotransferase mRNA expression in male and female rats of various ages. Chem Biol Interact 109 (1998) 299-313
41. Coughtrie M.W., and Johnston L.E. Interactions between dietary chemicals and human sulfotransferases - molecular mechanisms and clinical significance. Drug Metabolism Disposition 29 (2001) 522-528